News
Good news for Allecra Therapeutics as FDA approves its Exblifep antibiotic for complicated UTIs, but a rival therapy from Venatorx and Melinta is rejected.
Gestión de la calcinosis cutis VADEMECUM - 25/07/2023 PATOLOGÍAS Una revisión de expertos recientemente publicada resume los conocimientos sobre la evaluación de las intervenciones no farmacológicas y ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback